Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults
Clinical trial NCT02296541 · COMPLETED
Trial details
- NCT number
- NCT02296541
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-11-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.